GPR30 and Its Role in Breast Cancer
Author Information
Author(s): Poola Indira, Abraham Jessy, Liu Aiyi, Marshalleck Josephine J., DeWitty Robert L.
Primary Institution: Howard University School of Medicine
Hypothesis
GPR30 expression is down-regulated during breast tumorigenesis and may contribute to tumor progression.
Conclusion
Down-regulation of GPR30 could contribute to breast tumorigenesis and lymph node metastasis.
Supporting Evidence
- GPR30 mRNA levels were significantly down-regulated in cancer tissues compared to matched normal tissues.
- GPR30 expression was significantly lower in tumors from patients with lymph node metastasis.
- No significant association was found between GPR30 levels and other tumor characteristics.
Takeaway
This study found that a protein called GPR30, which helps regulate breast cells, is much lower in breast cancer tissues compared to normal tissues, especially in cases with lymph node spread.
Methodology
The study compared GPR30 mRNA levels in breast cancer tissues and matched normal tissues using RT quantitative real-time PCR.
Limitations
The variation in GPR30 expression did not correlate with tumor size, grade, stage, or other clinicopathological characteristics.
Participant Demographics
The study included 99 breast cancer patients with matched normal tissues, comprising both ERα-positive and ERα-negative samples.
Statistical Information
P-Value
p < 0.0001
Statistical Significance
p < 0.0001
Want to read the original?
Access the complete publication on the publisher's website